ALPN - ALPINE IMMUNE SCIENCES, INC.

QQQ $ 439.55 $ -0.26 (-0.06 %)

DIA $ 390.50 $ 1.74 (0.45 %)

SPY $ 517.10 $ 0.05 (0.01 %)

TLT $ 90.18 $ -0.55 (-0.61 %)

GLD $ 213.58 $ -0.63 (-0.29 %)

Previous Close

$ 64.7

Open

$ 64.62

Bid

$ 0.00 x 0

Ask

$ 0.00 x 0

Day's Range

$ 64.61 - $ 64.71

52 Week Range

$ 7.32 - $ 64.72

Volume

748,953

Average Volume

Market Cap

3.24B

Beta (5Y Monthly)

$ 1.01

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	03-19-2024	12-31-2023	10-K
2	11-14-2023	09-30-2023	10-Q
3	08-14-2023	06-30-2023	10-Q
4	05-11-2023	03-31-2023	10-Q
5	03-23-2023	12-31-2022	10-K
6	11-14-2022	09-30-2022	10-Q
7	08-11-2022	06-30-2022	10-Q
8	05-12-2022	03-31-2022	10-Q
9	03-17-2022	12-31-2021	10-K
10	11-10-2021	09-30-2021	10-Q
11	08-10-2021	06-30-2021	10-Q
12	05-13-2021	03-31-2021	10-Q
13	03-18-2021	12-31-2020	10-K
14	11-12-2020	09-30-2020	10-Q
15	08-11-2020	06-30-2020	10-Q
16	05-14-2020	03-31-2020	10-Q
17	03-30-2020	12-31-2019	10-K
18	11-14-2019	09-30-2019	10-Q
19	08-13-2019	06-30-2019	10-Q
20	05-09-2019	03-31-2019	10-Q
21	03-18-2019	12-31-2018	10-K
22	11-08-2018	09-30-2018	10-Q
23	08-09-2018	06-30-2018	10-Q
24	05-14-2018	03-31-2018	10-Q
25	03-28-2018	12-31-2017	10-K
26	11-14-2017	09-30-2017	10-Q
27	07-21-2017	06-30-2017	10-Q
28	05-02-2017	03-31-2017	10-Q
29	02-13-2017	12-31-2016	10-K
30	11-07-2016	09-30-2016	10-Q
31	08-02-2016	06-30-2016	10-Q
32	05-03-2016	03-31-2016	10-Q
33	03-08-2016	12-31-2015	10-K
34	11-03-2015	09-30-2015	10-Q
35	08-04-2015	06-30-2015	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

100b-vertex-pharma-working-to-recreate-10b-cystic-fibrosis-success---this-time-focused-on-pain-management-drugs

$100B Vertex Pharma Working To Recreate $1...
04/26/2024 18:34:08

Unlock Vertex Pharmaceuticals' pioneering treatments, from the groundbreaking Trikafta for cystic fibrosis to the promising...

TD Cowen Downgrades Alpine Immune Sciences...
04/16/2024 10:49:11

TD Cowen analyst Boris Peaker downgrades Alpine Immune Sciences (NASDAQ:ALPN) from Buy to Hold.

Leerink Partners Downgrades Alpine Immune ...
04/12/2024 13:54:30

Leerink Partners analyst Thomas Smith downgrades Alpine Immune Sciences (NASDAQ:ALPN) from Outperform to Market Perform and ...

vertexs-alpine-acquisition-unpacking-analyst-predictions-on-povetacicepts-potential-impact

Vertex's Alpine Acquisition: Unpacking Ana...
04/11/2024 18:47:33

Vertex Pharmaceuticals to acquire Alpine Immune Sciences for $4.9 billion, expanding into nephrology with promising APOL1-media...

stocks-bounce-back-with-tech-gold-gaining-after-modest-producer-inflation-data-whats-driving-markets-thursday

Stocks Bounce Back With Tech, Gold Gaining...
04/11/2024 18:13:17

Investors can breathe a sigh of relief on Thursday as last month’s Producer Price Index (PPI) inflation turned out slightly low...

Why Fastenal Shares Are Trading Lower By A...
04/11/2024 17:33:07

Shares of Fastenal Company (NASDAQ: FAST) fell sharply during Thursday’s session following worse-than-expected first-quarter f...

12-health-care-stocks-moving-in-thursdays-intraday-session

12 Health Care Stocks Moving In Thursday's...
04/11/2024 16:31:52

enliven-therapeutics-alpine-immune-sciences-janux-therapeutics-and-other-big-stocks-moving-higher-on-thursday

Enliven Therapeutics, Alpine Immune Scienc...
04/11/2024 14:01:51

U.S. stocks were mixed, with the Dow Jones index falling over 50 points on Thursday. Shares of Enliven Therapeutics, Inc. (NA...

vertex-pharmaceuticals-moves-beyond-10b-cystic-fibrosis-franchise-pays-around-5b-for-kidney-disease-player-alpine-immune

Vertex Pharmaceuticals Moves Beyond $10B C...
04/11/2024 13:01:11

Vertex Pharmaceuticals to acquire Alpine Immune Sciences for $4.9 billion in cash. Povetacicept, a potent dual antagonist of BA...

Wedbush Downgrades Alpine Immune Sciences ...
04/11/2024 12:18:27

Wedbush analyst Robert Driscoll downgrades Alpine Immune Sciences (NASDAQ:ALPN) from Outperform to Neutral.

12-health-care-stocks-moving-in-thursdays-pre-market-session

12 Health Care Stocks Moving In Thursday's...
04/11/2024 12:10:58

Wolfe Research Downgrades Alpine Immune Sc...
04/11/2024 12:02:53

Wolfe Research analyst Andy Chen downgrades Alpine Immune Sciences (NASDAQ:ALPN) from Outperform to Peer Perform.

wall-street-braces-for-another-red-day-ahead-of-more-inflation-data-while-bitcoin-holds-above-70k-analyst-sees-any-pullback-as-phenomenal-buying-opportunity

Wall Street Braces For Another Red Day Ahe...
04/11/2024 11:27:42

The negative mood on Wall Street may persist as investors await the release of another inflation report, which will have signif...

RBC Capital Downgrades Alpine Immune Scien...
04/11/2024 10:56:17

RBC Capital analyst Gregory Renza downgrades Alpine Immune Sciences (NASDAQ:ALPN) from Outperform to Sector Perform and rais...

why-rallybio-shares-are-trading-higher-by-around-78-here-are-20-stocks-moving-premarket

Why Rallybio Shares Are Trading Higher By ...
04/11/2024 10:14:41

Shares of Rallybio Corporation (NASDAQ: RLYB) rose sharply in today’s pre-market trading after the company announced a collabo...

Morgan Stanley Downgrades Alpine Immune Sc...
04/11/2024 09:46:08

Morgan Stanley analyst Michael Ulz downgrades Alpine Immune Sciences (NASDAQ:ALPN) from Overweight to Equal-Weight and raise...

why-bitcoin-linked-microstrategy-along-with-adial-pharmaceuticals-alpine-immune-sciences-marin-software-and-tesla-are-on-investors-radars-today

Why Bitcoin-Linked MicroStrategy Along Wit...
04/11/2024 02:19:07

On Wednesday, key U.S. stock indexes closed lower, as the Dow Jones Industrial Average fell by 1.1% to 38,461.51, the S&P 5...

Alpine Immune Sciences Shares Resumed Trade
04/10/2024 20:31:11

Trading Halt: Halt status updated at 4:25:...
04/10/2024 20:25:04

Alpine Immune Sciences Reports Updated Cli...
04/10/2024 20:16:05

-- Povetacicept administered subcutaneously once every four weeks continues to be well tolerated in IgA nephropathy, with UPCR ...